Dr. Peter Martin is part of the world-renowned Weill Cornell Lymphoma Program dedicated to delivering the most advanced treatment and comprehensive care for patients with all subtypes of lymphoma, including those with Hodgkin lymphoma, non-Hodgkin lymphomas, chronic lymphocytic leukemia (CLL), and Waldenstrom’s macroglobulinemia. For decades, the Weill Cornell Lymphoma Program has been leading the research revolution that is helping patients live longer and feel better. Through our clinical trials and research labs, we have helped develop breakthrough lymphoma treatments, including nearly every lymphoma drug that the Food and Drug Administration (FDA) has approved since 2000. We pride ourselves on exceptional outcomes, and we offer the most advanced diagnostic methods and treatments - whether you’re newly diagnosed or have a previously treated lymphoma. Learn more about Dr. Martin and our approach to care by visiting weillcornell.o... and weillcornell.o....
6 сен 2024
